Clinical Update 2/10/2021 Energy Drinks and Blood Pressure Which people are more likely to have cardiovascular side effects from energy drinks
Glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1 RA) increase glucose-dependent insulin secretion, decrease gastric emptying, and reduce postprandial glucagon secretion
#Pharmacovigilance #Semaglutide #ADR #DrugSafety #PvPI #PatientSafety #GLP1 #IPASF #HealthcareAwareness #PharmacyStudents #ClinicalResearch #MedicationSafety #CDSCO To view or add a comment, sign in More Relevant Posts Takedas ADZYNMA Gets FDA Boxed Warning After Fatal Antibody Case The FDA has mandated a boxed warning for Takedas ADZYNMA following a fatal case involving neutralizing antibodies, intensifying safety concerns around the rare disease therapy
Would you let a pharmaceutical company do this
European Journal of Pharmacology, 869 , 172891
Heiss CN, Manneras-Holm L, Lee YS et al (2021) The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism
